ARCHIVES

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

This article is from The Cancer Letter archive.

Vol. 39 No. 30 | July 25, 2013

Download PDF Visit The Full Archive

Related Articles

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Autologous BMT Equivalent To Allogeneic For Myeloma

December 31, 2010

In Brief: Stoval to Receive ACCC Award; Groopman, Sigal, Named to Board of Scientific Advisors

March 12, 1999

Finasteride Raises Odds Of Finding Fast-Growing Cancers Early, Study Says

September 28, 2007

DCPC Advisers Ok Four New Grant Programs To Foster Prevention

May 22, 1992